U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Gonadotropin deficiency

MedGen UID:
1632671
Concept ID:
C4552011
Disease or Syndrome
Synonym: Gonadotropin insufficiency
 
HPO: HP:0008213
Orphanet: ORPHA181387

Definition

A reduced ability to secrete gonadotropins, which are protein hormones secreted by gonadotrope cells of the anterior pituitary gland, including the hormones follitropin (FSH) and luteinizing hormone (LH). [from HPO]

Term Hierarchy

CClinical test,  RResearch test,  OOMIM,  GGeneReviews,  VClinVar  
  • Gonadotropin deficiency

Conditions with this feature

CHARGE syndrome
MedGen UID:
75567
Concept ID:
C0265354
Disease or Syndrome
CHD7 disorder encompasses the entire phenotypic spectrum of heterozygous CHD7 pathogenic variants that includes CHARGE syndrome as well as subsets of features that comprise the CHARGE syndrome phenotype. The mnemonic CHARGE syndrome, introduced in the premolecular era, stands for coloboma, heart defect, choanal atresia, retarded growth and development, genital hypoplasia, ear anomalies (including deafness). Following the identification of the genetic cause of CHD7 disorder, the phenotypic spectrum expanded to include cranial nerve anomalies, vestibular defects, cleft lip and/or palate, hypothyroidism, tracheoesophageal anomalies, brain anomalies, seizures, and renal anomalies. Life expectancy highly depends on the severity of manifestations; mortality can be high in the first few years when severe birth defects (particularly complex heart defects) are present and often complicated by airway and feeding issues. In childhood, adolescence, and adulthood, decreased life expectancy is likely related to a combination of residual heart defects, infections, aspiration or choking, respiratory issues including obstructive and central apnea, and possibly seizures. Despite these complications, the life expectancy for many individuals can be normal.
Hartsfield-Bixler-Demyer syndrome
MedGen UID:
335111
Concept ID:
C1845146
Congenital Abnormality
FGFR1-related Hartsfield syndrome comprises two core features: holoprosencephaly (HPE) spectrum disorder and ectrodactyly spectrum disorder. HPE spectrum disorder, resulting from failed or incomplete forebrain division early in gestation, includes alobar, semilobar, or lobar HPE. Other observed midline brain malformations include corpus callosum agenesis, absent septum pellucidum, absent olfactory bulbs and tracts, and vermian hypoplasia. Other findings associated with the HPE spectrum such as craniofacial dysmorphism, neurologic issues (developmental delay, spasticity, seizures, hypothalamic dysfunction), feeding problems, and endocrine issues (hypogonadotropic hypogonadism and central insipidus diabetes) are common. Ectrodactyly spectrum disorders are unilateral or bilateral malformations of the hands and/or feet characterized by a median cleft of hand or foot due to absence of the longitudinal central rays (also called split-hand/foot malformation). The number of digits on the right and left can vary. Polydactyly and syndactyly can also be seen.
Obesity due to pro-opiomelanocortin deficiency
MedGen UID:
341863
Concept ID:
C1857854
Disease or Syndrome
Early-onset obesity with adrenal insuficiency and red hair (OBAIRH) is an autosomal recessive endocrine disorder characterized by early-onset obesity due to severe hyperphagia, pigmentary abnormalities, mainly pale skin and red hair, and secondary hypocortisolism. In the neonatal period, affected individuals are prone to hypoglycemia, hyperbilirubinemia, and cholestasis that may result in death if not treated. The disorder results from mutation in the POMC gene, which encodes a preproprotein that is processed into a range of bioactive peptides, including alpha-melanocyte-stimulating hormone (MSH) and ACTH (summary by Kuhnen et al., 2016 and Clement et al., 2008).
Brain-lung-thyroid syndrome
MedGen UID:
369694
Concept ID:
C1970269
Disease or Syndrome
NKX2-1-related disorders range from benign hereditary chorea (BHC) to choreoathetosis, congenital hypothyroidism, and neonatal respiratory distress (also known as brain-lung-thyroid syndrome). Childhood-onset chorea, the hallmark of NKX2-1-related disorders, may or may not be associated with respiratory distress syndrome or congenital hypothyroidism. Chorea generally begins in early infancy or about age one year (most commonly) or in late childhood or adolescence, and progresses into the second decade after which it remains static or (rarely) remits. Pulmonary disease, the second most common manifestation, can include respiratory distress syndrome in neonates, interstitial lung disease in young children, and pulmonary fibrosis in older persons. The risk for pulmonary carcinoma is increased in young adults with an NKX2-1-related disorder. Thyroid dysfunction, the result of dysembryogenesis, can present as congenital hypothyroidism or compensated hypothyroidism. The risk for thyroid cancer is unknown and may not be increased. In one review, 50% of affected individuals had the full brain-lung-thyroid syndrome, 30% had involvement of brain and thyroid only, and 13% had isolated chorea only.
Non-acquired combined pituitary hormone deficiency with spine abnormalities
MedGen UID:
483740
Concept ID:
C3489787
Disease or Syndrome
Combined pituitary hormone deficiency-3 (CPHD3) is an autosomal recessive disorder characterized by hypopituitarism with structural anterior pituitary defects and cervical abnormalities with or without restricted neck rotation. Some patients have sensorineural hearing loss (summary by Rajab et al., 2008). For a discussion of phenotypic and genetic heterogeneity of combined pituitary hormone deficiency, see CPHD1 (613038).

Professional guidelines

PubMed

Takeshima T, Karibe J, Saito T, Kuroda S, Komeya M, Uemura H, Yumura Y
Int J Urol 2024 Jan;31(1):17-24. Epub 2023 Sep 22 doi: 10.1111/iju.15301. PMID: 37737473
Watson S, Fuqua JS, Lee PA
Pediatr Endocrinol Rev 2014 Feb;11 Suppl 2:230-9. PMID: 24683947
Salenave S, Trabado S, Maione L, Brailly-Tabard S, Young J
Ann Endocrinol (Paris) 2012 Apr;73(2):141-6. Epub 2012 Apr 25 doi: 10.1016/j.ando.2012.03.040. PMID: 22541999

Recent clinical studies

Etiology

Takeshima T, Karibe J, Saito T, Kuroda S, Komeya M, Uemura H, Yumura Y
Int J Urol 2024 Jan;31(1):17-24. Epub 2023 Sep 22 doi: 10.1111/iju.15301. PMID: 37737473
Cocco C, Brancia C, D'Amato F, Noli B
Mol Cell Endocrinol 2014 Mar 25;385(1-2):97-104. Epub 2013 Oct 20 doi: 10.1016/j.mce.2013.10.009. PMID: 24153235
Darzy KH
Nat Clin Pract Endocrinol Metab 2009 Feb;5(2):88-99. doi: 10.1038/ncpendmet1051. PMID: 19165221
Ascoli P, Cavagnini F
Pituitary 2006;9(4):335-42. doi: 10.1007/s11102-006-0416-5. PMID: 17077946
Baker HW
Endocrinol Metab Clin North Am 1994 Dec;23(4):783-93. PMID: 7705320

Diagnosis

Yavropoulou MP, Tsoli M, Kaltsas G
Handb Clin Neurol 2021;181:127-135. doi: 10.1016/B978-0-12-820683-6.00009-9. PMID: 34238452
Liu E, Rohr A, AlMehthel M
BMJ Case Rep 2020 Oct 4;13(10) doi: 10.1136/bcr-2020-235077. PMID: 33012710Free PMC Article
Butler G, Purushothaman P
Minerva Pediatr 2020 Dec;72(6):484-490. Epub 2020 Aug 4 doi: 10.23736/S0026-4946.20.05968-X. PMID: 32748610
Watson S, Fuqua JS, Lee PA
Pediatr Endocrinol Rev 2014 Feb;11 Suppl 2:230-9. PMID: 24683947
Ascoli P, Cavagnini F
Pituitary 2006;9(4):335-42. doi: 10.1007/s11102-006-0416-5. PMID: 17077946

Therapy

Takeshima T, Karibe J, Saito T, Kuroda S, Komeya M, Uemura H, Yumura Y
Int J Urol 2024 Jan;31(1):17-24. Epub 2023 Sep 22 doi: 10.1111/iju.15301. PMID: 37737473
Ulloa-Aguirre A, Lira-Albarrán S
Prog Mol Biol Transl Sci 2016;143:121-174. Epub 2016 Sep 13 doi: 10.1016/bs.pmbts.2016.08.003. PMID: 27697201
Watson S, Fuqua JS, Lee PA
Pediatr Endocrinol Rev 2014 Feb;11 Suppl 2:230-9. PMID: 24683947
Ascoli P, Cavagnini F
Pituitary 2006;9(4):335-42. doi: 10.1007/s11102-006-0416-5. PMID: 17077946
Matsumoto AM
Endocrinol Metab Clin North Am 1994 Dec;23(4):857-75. PMID: 7705324

Prognosis

Takeshima T, Karibe J, Saito T, Kuroda S, Komeya M, Uemura H, Yumura Y
Int J Urol 2024 Jan;31(1):17-24. Epub 2023 Sep 22 doi: 10.1111/iju.15301. PMID: 37737473
Butler G, Purushothaman P
Minerva Pediatr 2020 Dec;72(6):484-490. Epub 2020 Aug 4 doi: 10.23736/S0026-4946.20.05968-X. PMID: 32748610
Kohva E, Huopio H, Hietamäki J, Hero M, Miettinen PJ, Raivio T
Hum Reprod 2019 May 1;34(5):863-871. doi: 10.1093/humrep/dez040. PMID: 31067328Free PMC Article
Jonasdottir AD, Sigurjonsson P, Olafsson IH, Karason S, Sigthorsson G, Sigurjonsdottir HA
Brain Inj 2018;32(3):310-317. Epub 2017 Dec 28 doi: 10.1080/02699052.2017.1418906. PMID: 29283287
Darzy KH
Nat Clin Pract Endocrinol Metab 2009 Feb;5(2):88-99. doi: 10.1038/ncpendmet1051. PMID: 19165221

Clinical prediction guides

Takeshima T, Karibe J, Saito T, Kuroda S, Komeya M, Uemura H, Yumura Y
Int J Urol 2024 Jan;31(1):17-24. Epub 2023 Sep 22 doi: 10.1111/iju.15301. PMID: 37737473
Butler G, Purushothaman P
Minerva Pediatr 2020 Dec;72(6):484-490. Epub 2020 Aug 4 doi: 10.23736/S0026-4946.20.05968-X. PMID: 32748610
Maggi M, Buvat J
J Sex Med 2013 Jan;10(1):285-93. Epub 2012 Feb 29 doi: 10.1111/j.1743-6109.2012.02678.x. PMID: 22376050
Salenave S, Trabado S, Maione L, Brailly-Tabard S, Young J
Ann Endocrinol (Paris) 2012 Apr;73(2):141-6. Epub 2012 Apr 25 doi: 10.1016/j.ando.2012.03.040. PMID: 22541999
Tziaferi V, Kelberman D, Dattani MT
Sex Dev 2008;2(4-5):194-9. Epub 2008 Nov 5 doi: 10.1159/000152035. PMID: 18987493

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...